The Association of the British Pharmaceutical Industry (ABPI) exists to make the UK the best place in the world to research, develop and use new medicines and vaccines. We represent companies of all sizes who invest in discovering the medicines of the future.
Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines.
Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.
The ABPI is currently looking for two people with direct experience of multimorbidity to join its Multimorbidity Action Group (MAG). ‘Multimorbidity’, or ‘multiple long-term conditions’, refers to the diagnoses of two or more diseases, in the same person, at the same time.
We are asking these individuals to join our MAG and to represent the patient voice alongside NHS clinicians, academic researchers, and pharmaceutical companies.
The ABPI MAG has come together to make an impact in research, clinical care, and treatments, to improve the lives of people living with multiple long-term conditions. We believe that these patients are currently underserved, so we are seeking to make a difference across the NHS and within government towards our vision (see below).
We would like to work with these two experts by experience who would be interested in helping advise and guide our work as we improve the culture and help guide policy development in this area. As members of the ABPI MAG, the two experts by experience will contribute to delivering the group’s 2021 objectives (see below):